The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
RNA interference in the clinic: challenges and future directions
Open accessAbstract
Inherent difficulties with blocking many desirable targets using conventional approaches have prompted many to consider using RNA interference (RNAi) as a therapeutic approach. Although exploitation of RNAi has immense potential as a cancer therapeutic, many physiological obstacles stand in the way of successful and efficient delivery. This Review explores current challenges to the development of synthetic RNAi-based therapies and considers new approaches to circumvent biological barriers, to avoid intolerable side effects and to achieve controlled and sustained release.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Neutrophil Extracellular Traps Kill Bacteria
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y., & Zychlinsky, A. (2004) · Science · doi:10.1126/science.1092385 · Cited by 10,268
Semiconductor Nanocrystals as Fluorescent Biological Labels
Bruchez, M., Moronne, M., Gin, P., Weiss, S., & Alivisatos, A. P. (1998) · Science · doi:10.1126/science.281.5385.2013 · Cited by 8,613
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,415
Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S., & Fujita, T. (2004) · Nature Immunology · doi:10.1038/ni1087 · Cited by 3,929
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
Druker, B. J., Guilhot, F., O'Brien, S. G., Gathmann, I., Kantarjian, H., Gattermann, N., Deininger, M. W. N., Silver, R. T., Goldman, J. M., Stone, R. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062867 · Cited by 3,488
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Argonaute2 is the catalytic engine of mammalian RNAi
Liu, J., Carmell, M. A., Rivas, F. V., Marsden, C. G., Thomson, J. M., Song, J.-J., Hammond, S. M., Joshua-Tor, L., & Hannon, G. J. (2004) · Science · doi:10.1126/science.1102513 · Cited by 2,796
MicroRNA biogenesis: coordinated cropping and dicing
Kim, V. N. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1644 · Cited by 2,546
Mechanisms of gene silencing by double-stranded RNA
Meister, G., & Tuschl, T. (2004) · Nature · doi:10.1038/nature02873 · Cited by 2,539
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Expression profiling reveals off-target gene regulation by RNAi
Jackson, A. L., Bartz, S. R., Schelter, J., Kobayashi, S. V., Burchard, J., Mao, M., Li, B., Cavet, G., & Linsley, P. S. (2003) · Nature Biotechnology · doi:10.1038/nbt831 · Cited by 2,370
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs
Meister, G., Landthaler, M., Patkaniowska, A., Dorsett, Y., Teng, G., & Tuschl, T. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.07.007 · Cited by 2,052
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., Marion, P., Salazar, F., & Kay, M. A. (2006) · Nature · doi:10.1038/nature04791 · Cited by 1,677
Smith, I., Procter, M., Gelber, R. D., Guillaume, S., Feyereislova, A., Dowsett, M., Goldhirsch, A., Untch, M., Mariani, G., Baselga, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60028-2 · Cited by 1,507
Self-citationThe Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution
Farh, K. K.-H., Grimson, A., Jan, C., Lewis, B. P., Johnston, W. K., Lim, L. P., Burge, C. B., & Bartel, D. P. (2005) · Science · doi:10.1126/science.1121158 · Cited by 1,484
Single-Stranded Antisense siRNAs Guide Target RNA Cleavage in RNAi
Martinez, J., Patkaniowska, A., Urlaub, H., Lührmann, R., & Tuschl, T. (2002) · Cell · doi:10.1016/s0092-8674(02)00908-x · Cited by 1,459
Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs
BOHNSACK, M. T., CZAPLINSKI, K., & GÖRLICH, D. (2004) · RNA · doi:10.1261/rna.5167604 · Cited by 1,433
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., & MacLachlan, I. (2005) · Nature Biotechnology · doi:10.1038/nbt1081 · Cited by 1,250
Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., & Jain, R. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0074 · Cited by 1,189
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akinc, A., Zumbuehl, A., Goldberg, M., Leshchiner, E. S., Busini, V., Hossain, N., Bacallado, S. A., Nguyen, D. N., Fuller, J., Alvarez, R., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1402 · Cited by 1,150
RNAi therapeutics: a potential new class of pharmaceutical drugs
Bumcrot, D., Manoharan, M., Koteliansky, V., & Sah, D. W. Y. (2006) · Nature Chemical Biology · doi:10.1038/nchembio839 · Cited by 1,085
Illuminating the silence: understanding the structure and function of small RNAs
Rana, T. M. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2085 · Cited by 1,083
Jackson, A. L., & Linsley, P. S. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3010 · Cited by 1,083
Strategies for silencing human disease using RNA interference
Kim, D. H., & Rossi, J. J. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2006 · Cited by 1,078
Unlocking the potential of the human genome with RNA interference
Hannon, G. J., & Rossi, J. J. (2004) · Nature · doi:10.1038/nature02870 · Cited by 1,064
Dobrovolskaia, M. A., Aggarwal, P., Hall, J. B., & McNeil, S. E. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800032f · Cited by 1,022
Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects
Maeda, H. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100070g · Cited by 998
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs
Wolfrum, C., Shi, S., Jayaprakash, K. N., Jayaraman, M., Wang, G., Pandey, R. K., Rajeev, K. G., Nakayama, T., Charrise, K., Ndungo, E. M., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1339 · Cited by 974
Lipid-like materials for low-dose, in vivo gene silencing
Love, K. T., Mahon, K. P., Levins, C. G., Whitehead, K. A., Querbes, W., Dorkin, J. R., Qin, J., Cantley, W., Qin, L. L., Racie, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910603106 · Cited by 969
Widespread siRNA “off-target” transcript silencing mediated by seed region sequence complementarity
Jackson, A. L., Burchard, J., Schelter, J., Chau, B. N., Cleary, M., Lim, L., & Linsley, P. S. (2006) · RNA · doi:10.1261/rna.25706 · Cited by 956
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
Kleinman, M. E., Yamada, K., Takeda, A., Chandrasekaran, V., Nozaki, M., Baffi, J. Z., Albuquerque, R. J. C., Yamasaki, S., Itaya, M., Pan, Y., et al. (2008) · Nature · doi:10.1038/nature06765 · Cited by 929
Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing
Jackson, A. L., Burchard, J., Leake, D., Reynolds, A., Schelter, J., Guo, J., Johnson, J. M., Lim, L., Karpilow, J., Nichols, K., et al. (2006) · RNA · doi:10.1261/rna.30706 · Cited by 789
Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer
Merritt, W. M., Lin, Y. G., Han, L. Y., Kamat, A. A., Spannuth, W. A., Schmandt, R., Urbauer, D., Pennacchio, L. A., Cheng, J.-F., Nick, A. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0803785 · Cited by 712
Self-citationDendrimer toxicity: Let's meet the challenge
Jain, K., Kesharwani, P., Gupta, U., & Jain, N. K. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.027 · Cited by 710
Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery
Landen, C. N., Chavez-Reyes, A., Bucana, C., Schmandt, R., Deavers, M. T., Lopez-Berestein, G., & Sood, A. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0530 · Cited by 675
Self-citationBreaking down the barriers: siRNA delivery and endosome escape
Dominska, M., & Dykxhoorn, D. M. (2010) · Journal of Cell Science · doi:10.1242/jcs.066399 · Cited by 630
Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells
Czauderna, F. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg393 · Cited by 623
Bartlett, D. W. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj439 · Cited by 592
Kinetic analysis of the RNAi enzyme complex
Haley, B., & Zamore, P. D. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb780 · Cited by 544
Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs
Khan, A. A., Betel, D., Miller, M. L., Sander, C., Leslie, C. S., & Marks, D. S. (2009) · Nature Biotechnology · doi:10.1038/nbt.1543 · Cited by 534
Dose‐Finding Based on Efficacy–Toxicity Trade‐Offs
Thall, P. F., & Cook, J. D. (2004) · Biometrics · doi:10.1111/j.0006-341x.2004.00218.x · Cited by 522
Translation Repression in Human Cells by MicroRNA-Induced Gene Silencing Requires RCK/p54
Chu, C.-Y., & Rana, T. M. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040210 · Cited by 520
Common genetic variants account for differences in gene expression among ethnic groups
Spielman, R. S., Bastone, L. A., Burdick, J. T., Morley, M., Ewens, W. J., & Cheung, V. G. (2007) · Nature Genetics · doi:10.1038/ng1955 · Cited by 515
Survival of Cancer Cells Is Maintained by EGFR Independent of Its Kinase Activity
Weihua, Z., Tsan, R., Huang, W.-C., Wu, Q., Chiu, C.-H., Fidler, I. J., & Hung, M.-C. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.03.015 · Cited by 490
HUNTER, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.008 · Cited by 456
Robbins, M., Judge, A., & MacLachlan, I. (2009) · Oligonucleotides · doi:10.1089/oli.2009.0180 · Cited by 449
Lipid‐based nanotherapeutics for siRNA delivery
Schroeder, A., Levins, C. G., Cortez, C., Langer, R., & Anderson, D. G. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02189.x · Cited by 447
Regulation of Tumor Angiogenesis by EZH2
Lu, C., Han, H. D., Mangala, L. S., Ali-Fehmi, R., Newton, C. S., Ozbun, L., Armaiz-Pena, G. N., Hu, W., Stone, R. L., Munkarah, A., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.06.016 · Cited by 399
Self-citationHeidel, J. D., Yu, Z., Liu, J. Y.-C., Rele, S. M., Liang, Y., Zeidan, R. K., Kornbrust, D. J., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701458104 · Cited by 382
Swarup, V., & Rajeswari, M. R. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.01.051 · Cited by 379
Single-Nucleotide Polymorphisms Inside MicroRNA Target Sites Influence Tumor Susceptibility
Nicoloso, M. S., Sun, H., Spizzo, R., Kim, H., Wickramasinghe, P., Shimizu, M., Wojcik, S. E., Ferdin, J., Kunej, T., Xiao, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3541 · Cited by 378
Self-citationKim, S. H., Jeong, J. H., Lee, S. H., Kim, S. W., & Park, T. G. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.008 · Cited by 362
Detection of tumor messenger RNA in the serum of patients with malignant melanoma.
KOPRESKI, M. S., Benko, F. A., Kwak, L. W., & Gocke, C. D. (1999) · PubMed · Cited by 359
Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo
Takeshita, F., Minakuchi, Y., Nagahara, S., Honma, K., Sasaki, H., Hirai, K., Teratani, T., Namatame, N., Yamamoto, Y., Hanai, K., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501753102 · Cited by 355
Oxygen Radical-Mediated Pulmonary Toxicity Induced by Some Cationic Liposomes
Dokka, S., Toledo, D., Shi, X., Castranova, V., & Rojanasakul, Y. (2000) · Pharmaceutical Research · doi:10.1023/a:1007504613351 · Cited by 349 · cited 1×
“Additionally, cationic liposomes have shown dose-dependent toxicity and pulmonary inflammation that arises as a result of reactive oxygen intermediate”
BackgroundSustained Small Interfering RNA Delivery by Mesoporous Silicon Particles
Tanaka, T., Mangala, L. S., Vivas-Mejia, P. E., Nieves-Alicea, R., Mann, A. P., Mora, E., Han, H.-D., Shahzad, M. M. K., Liu, X., Bhavane, R., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3931 · Cited by 316
Self-citationQuantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference
Tan, W. B., Jiang, S., & Zhang, Y. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.11.018 · Cited by 295
Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles
Han, H. D., Mangala, L. S., Lee, J. W., Shahzad, M. M. K., Kim, H. S., Shen, D., Nam, E. J., Mora, E. M., Stone, R. L., Lu, C., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0005 · Cited by 282
Self-citationIdentification of RNA Sequence Motifs Stimulating Sequence-Specific TLR8-Dependent Immune Responses
Forsbach, A., Nemorin, J.-G., Montino, C., Müller, C., Samulowitz, U., Vicari, A. P., Jurk, M., Mutwiri, G. K., Krieg, A. M., Lipford, G. B., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.3729 · Cited by 281
The Receptor-Mediated Endocytosis of Nonspherical Particles
Decuzzi, P., & Ferrari, M. (2008) · Biophysical Journal · doi:10.1529/biophysj.107.120238 · Cited by 278
Castanotto, D., Sakurai, K., Lingeman, R., Li, H., Shively, L., Aagaard, L., Soifer, H., Gatignol, A., Riggs, A., & Rossi, J. J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm543 · Cited by 269
Frontiers in cancer nanomedicine: directing mass transport through biological barriers
Ferrari, M. (2010) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.12.007 · Cited by 255
Telomerase RNA as a detection marker in the serum of breast cancer patients.
Chen, X. Q., Bonnefoi, H. R., Pelte, M. F., Lyautey, J., Lederrey, C., Movarekhi, S., Schaeffer, P., Mulcahy, H. E., Meyer, P., Stroun, M., et al. (2000) · PubMed · Cited by 242
Enabling individualized therapy through nanotechnology
Sakamoto, J. H., van de Ven, A. L., Godin, B., Blanco, E., Serda, R. E., Grattoni, A., Ziemys, A., Bouamrani, A., Hu, T., Ranganathan, S. I., et al. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2009.12.011 · Cited by 229
Cationic lipids enhance siRNA-mediated interferon response in mice
Ma, Z., Li, J., He, F., Wilson, A., Pitt, B., & Li, S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.041 · Cited by 225
Pancreatic cancer microenvironment
Kleeff, J., Beckhove, P., Esposito, I., Herzig, S., Huber, P. E., Löhr, J. M., & Friess, H. (2007) · International Journal of Cancer · doi:10.1002/ijc.22871 · Cited by 225
Extracellular Barriers to in Vivo PEI and PEGylated PEI Polyplex-Mediated Gene Delivery to the Liver
Burke, R. S., & Pun, S. H. (2008) · Bioconjugate Chemistry · doi:10.1021/bc700388u · Cited by 221
3-D Tissue Culture Systems for the Evaluation and Optimization of Nanoparticle-Based Drug Carriers
Goodman, T. T., Ng, C. P., & Pun, S. H. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800233a · Cited by 207
Phagocytosis Independent Extracellular Nanoparticle Clearance by Human Immune Cells
Bartneck, M., Keul, H. A., Zwadlo-Klarwasser, G., & Groll, J. (2010) · Nano Letters · doi:10.1021/nl902830x · Cited by 192
Microvascular architecture of experimental colon tumors in the rat.
Skinner, S. A., Tutton, P. J. M., & O’Brien, P. E. (1990) · PubMed · Cited by 180
Design maps for nanoparticles targeting the diseased microvasculature
Decuzzi, P., & Ferrari, M. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.09.025 · Cited by 168
Pillé, J.-Y., Li, H., Blot, E., Bertrand, J.-R., Pritchard, L.-L., Opolon, P., Maksimenko, A., Lu, H., Vannier, J.-P., Soria, J., et al. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.1019 · Cited by 167
Targeted Nanoparticles That Deliver a Sustained, Specific Release of Paclitaxel to Irradiated Tumors
Passarella, R. J., Spratt, D. E., van der Ende, A. E., Phillips, J. G., Wu, H., Sathiyakumar, V., Zhou, L., Hallahan, D. E., Harth, E. M., & Diaz, R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0339 · Cited by 154
Ahmed, A. A., Lü, Z., Jennings, N. B., Etemadmoghadam, D., Capalbo, L., Jacamo, R. O., Barbosa‐Morais, N. L., Le, X., Vivas‐Mejía, P. E., Lopez‐Berestein, G., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.06.018 · Cited by 152
Self-citationPillé, J.-Y., Li, H., Blot, E., Bertrand, J., Pritchard, L. L., Opolon, P., Maksimenko, A., Lu, H., Vannier, J., Soria, J., et al. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.ft-248 · Cited by 140
FERM control of FAK function: Implications for cancer therapy
Lim, S., Mikolon, D., Stupack, D. G., & Schlaepfer, D. D. (2008) · Cell Cycle · doi:10.4161/cc.6367 · Cited by 134
Kim, S. H., Mok, H., Jeong, J. H., Kim, S. W., & Park, T. G. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050289f · Cited by 129
Maintaining the silence: reflections on long-term RNAi
Raemdonck, K., Vandenbroucke, R. E., Demeester, J., Sanders, N. N., & Smedt, S. C. D. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.06.008 · Cited by 124
Mathematical modeling of cancer progression and response to chemotherapy
Sanga, S., Sinek, J. P., Frieboes, H. B., Mauro Ferrari, B., Fruehauf, J. P., & Vittorio Cristini, C. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.10.1361 · Cited by 122
The Effective Dispersion of Nanovectors Within the Tumor Microvasculature
Decuzzi, P., Causa, F., Mauro Ferrari, B., & Netti, P. A. (2006) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-9072-6 · Cited by 109
Coexpression of Argonaute-2 enhances RNA interference toward perfect match binding sites
Diederichs, S., Jung, S., Rothenberg, S. M., Smolen, G. A., Mlody, B., & Haber, D. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800803105 · Cited by 101
Structural insights into RNA interference
Sashital, D. G., & Doudna, J. A. (2010) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2009.12.001 · Cited by 90
Toxicogenomics of Cationic Lipid-based Vectors for Gene Therapy: Impact of Microarray Technology
Omidi, Y., Barar, J., & Akhtar, S. (2005) · Current Drug Delivery · doi:10.2174/156720105774370249 · Cited by 89
Regulating the Regulators: Posttranslational Modifications of RNA Silencing Factors
Heo, I., & Kim, V. N. (2009) · Cell · doi:10.1016/j.cell.2009.09.013 · Cited by 74
The Dicey Role of Dicer: Implications for RNAi Therapy
Merritt, W. M., Bar‐Eli, M., & Sood, A. K. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2536 · Cited by 68
Self-citationThe Tangled Webs That Neutrophils Weave
Lee, W. L., & Grinstein, S. (2004) · Science · doi:10.1126/science.1095484 · Cited by 58
Dual targeting of EphA2 and FAK in ovarian carcinoma
Shahzad, M., Lu, C.-H., Lee, J., Stone, R., Mitra, R., Mangala, L., Lu, Y.-L., Baggerly, K., Danes, C., Nick, A., et al. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.11.8523 · Cited by 57
Self-citationHogrefe, R. I., Lebedev, A. V., Zon, G., Pirollo, K. F., Rait, A. S., Zhou, Q., Yu, W., & Chang, E. H. (2006) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770600793885 · Cited by 56
Sardiello, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg123 · Cited by 52
Chemically modified siRNA prolonged RNA interference in renal disease
Takabatake, Y., Isaka, Y., Mizui, M., Kawachi, H., Takahara, S., & Imai, E. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.189 · Cited by 43
In Vivo Imaging of RNA Interference
Hong, H., Zhang, Y., & Cai, W. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.066878 · Cited by 36
Abdrakhmanova, A., Schlichting, R., Hunter, C. L., Glueckmann, M., Lenz, C., Echeverri, C. J., Sönnichsen, B., Jung, A., & Weiss-Haljiti, C. (2009) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-009-3028-x · Cited by 4
Cited by
Drugging the undruggable RAS: Mission Possible?
Cox, A. D., Fesik, S. W., Kimmelman, A. C., Luo, J., & Der, C. J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4389 · Cited by 1,997
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,901
The role of non-coding RNAs in oncology
Slack, F. J., & Chinnaiyan, A. M. (2019) · Cell · doi:10.1016/j.cell.2019.10.017 · Cited by 1,619
MicroRNAs and other non-coding RNAs as targets for anticancer drug development
Ling, H., Fabbri, M., & Calin, G. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4140 · Cited by 1,465
Self-citationTreating metastatic cancer with nanotechnology
Schroeder, A., Heller, D. A., Winslow, M. M., Dahlman, J. E., Pratt, G. W., Langer, R., Jacks, T., & Anderson, D. G. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3180 · Cited by 1,159
Metadata
- Authors
- Pecot, C. V., Calin, G. A., Coleman, R. L., Lopez-Berestein, G., & Sood, A. K.
- Venue
- Nature Reviews Cancer
- Published
- 2010-12-16
- Volume
- 11
- Issue
- 1
- Pages
- 59-67
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2040237389
- Cited by
- 820
- References
- 97
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.